APA (7th ed.) Citation

M, R., C, D., P, B., S, P., A, P., L, D., . . . M, M. (2017). Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma. Clinica chimica acta; international journal of clinical chemistry, 472, 26. https://doi.org/10.1016/j.cca.2017.07.012

Chicago Style (17th ed.) Citation

M, Rousset, et al. "Trough Dabrafenib Plasma Concentrations Can Predict Occurrence of Adverse Events Requiring Dose Reduction in Metastatic Melanoma." Clinica Chimica Acta; International Journal of Clinical Chemistry 472 (2017): 26. https://doi.org/10.1016/j.cca.2017.07.012.

MLA (9th ed.) Citation

M, Rousset, et al. "Trough Dabrafenib Plasma Concentrations Can Predict Occurrence of Adverse Events Requiring Dose Reduction in Metastatic Melanoma." Clinica Chimica Acta; International Journal of Clinical Chemistry, vol. 472, 2017, p. 26, https://doi.org/10.1016/j.cca.2017.07.012.